CARBIDOPA AND LEVODOPA
Generic: CARBIDOPA AND LEVODOPA
Zydus Pharmaceuticals USA Inc.Manufacturer
ORALRoute
CARBIDOPAActive Substance
2015-01-07Original Approval
CARBIDOPA AND LEVODOPA is FDA application NDA203312, sponsored by IMPAX. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2025-10-07
Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising PharmaProduct mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and
Class II2017-01-12
Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b) 500-count bottlesFailed Dissolution Specifications
Top Reported Reactions
1
DRUG INEFFECTIVE
948 reports
2
FALL
801 reports
3
HALLUCINATION
759 reports
4
DEATH
570 reports
5
DYSKINESIA
496 reports
6
DIZZINESS
480 reports
7
NAUSEA
479 reports
8
FATIGUE
478 reports
9
TREMOR
476 reports
10
PARKINSON^S DISEASE
471 reports